Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Topotecan for Proliferative Vitre}
NCT06425419Phase 1Not yet recruiting
- Sponsor
- Massachusetts Eye and Ear
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Phase 1 trial, sponsored by Massachusetts Eye and Ear. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06425419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06425419.